Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic Among Next Drugs Up for Medicare Price Negotiations
Medicare drug price negotiations to target Ozempic, Wegovy and other drugs
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
15 Costly Medicare Drugs Selected for Next Round of Price Negotiations
Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations for 10 drugs whose lower prices take effect in 2026. T
8h
on MSN
In single bust, U.S. border officers find what they say is 9 pounds of drugs worth $158K
A drug interception this week at the Brownsville and Matamoros International Bridge resulted in officers finding $158,145 ...
7h
on MSN
Health Rounds: New method may eliminate need for cold storage of drugs, vaccines
A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold, potentially eliminating ...
14h
US Health Secretary: Price of Targeted Drugs Should Be Lowered
WASHINGTON (Reuters) - U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to ...
11h
on MSN
Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations
Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Medicare
Ozempic
Wegovy
Joe Biden
Novo Nordisk
Feedback